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Dr. Julio Frenk, the former dean of the Harvard School of Public Health, has said (in a personal
communication) that “The greatest threat to global health is dichotomous thinking, thinking
that things are either black or white, all good or all bad.” This sort of thinking is simplistic and
often prevents us from seeing how to best solve our most serious problems, pitting advocates
against each other and blinding different stakeholders to innovations and solutions that involve
collaboration, dialogue, and compromise.
The term “neglected tropical diseases” (NTDs) came into use some ten years ago to refer to
a group of diseases that occur most commonly in the tropics and subtropics [1,2]. Although
NTDs cause considerable morbidity and human suffering, progress in controlling them
remained limited, in large part because they affect marginalized and impoverished populations.
The NTD label provided a greater profile, facilitated advocacy, and, especially in the last couple
of years, caught the attention of policy makers, philanthropists, and donors [3].
For a number of years, we have used a distinction between those NTDs whose treatment
and prevention involve mass drug administration (MDA) and those which involve individual
case finding and case management. We have labeled the former the “preventive chemotherapy
and transmission control” (PCT) NTDs and the latter the “innovative and intensified disease
management” (IDM) NTDs. The Department of Control of Neglected Tropical Diseases of the
World Health Organization (WHO), for example, uses this distinction and accordingly has
classified some diseases as “IDM” and others as “PCT” (see: http://www.who.int/neglected_
diseases). Most people working in the NTD field have accepted and adhere to this distinction.
PCT focuses on those NTDs for which a global strategy exists and for which tools are readily
available for large-scale deployment [4]. The most prominent examples of NTDs that have been
allocated to the PCT group are lymphatic filariasis, onchocerciasis, schistosomiasis, and soil-
transmitted helminthiasis; the main tool for their control is the periodic administration of effi-
cacious, safe, and inexpensive (usually donated) drugs to entire at-risk populations without
prior individual diagnosis [1,2,5,6]. IDM, on the other hand, focuses on those NTDs that cur-
rently lack appropriate tools for large-scale use. Hence, in general, the IDMNTDs are currently
more difficult and costly to manage than some of the PCT diseases, as there are inherent chal-
lenges for their diagnosis, treatment, and follow-up. Buruli ulcer [7], Chagas disease [8], human
African trypanosomiasis [9], and leishmaniasis [10] are examples of IDMNTDs. The separa-
tion of NTDs into mutually exclusive groups has been further cemented by referral to “tool-
ready” and “tool-deficient” diseases—a terminology used byWHO [4] and the Centers for
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Disease Control and Prevention (CDC; see: http://www.cdc.gov/globalhealth/ntd/diseases/),
among other organizations.
In our view—and that of others [11]—the distinction between PCT and IDM and between
“tool-ready” and “tool-deficient” NTDs needs careful rethinking. Indeed, we feel that the shelf
life of this separation has expired. For example, look at the case of yaws. Yaws is an NTD
caused by a spirochete related to the organism that causes syphilis [12]. The traditional
approach to address yaws was to identify persons with the characteristic skin ulcers and treat
them with injectable penicillin, together with skin care and careful follow-up. But recently, it
has been shown that mass administration of oral azithromycin can cure almost all cases of
yaws and effectively stop transmission [13]. This means that a disease formerly classified as an
IDMNTDmight be reclassified as a PCT NTD. It must be noted, however, that not all yaws-
like lesions are, in fact, yaws. Careful diagnosis is needed to distinguish them and provide
appropriate case management. Further, yaws leg ulcers will often persist after azithromycin
treatment, and there will be a need to find such patients for follow-up. Taken together, yaws
eradication will require both MDA and case identification as well as rigorous surveillance and
adequate responses tailored to specific social-ecological contexts.
Other so-called PCT NTDs are not so clear-cut as to fit neatly into either one or the other
category. Lymphatic filariasis, for example, can be prevented with MDA, but millions of people
who already have filariasis-associated lymphedema require careful case management, including
scrupulous hygiene and skin care, which may need to be lifelong [14,15]. Such case manage-
ment reduces the frequency of secondary bacterial infections and arrests, reverses, or slows
progression of disease [14,15]. Additionally, surgery is required to address the massive burden
of filariasis-associated hydrocele [16]. Putting lymphatic filariasis into the PCT NTD box has
diminished the importance of case management and resulted in this crucial component of lym-
phatic filariasis elimination being neglected and downplayed. Lymphatic filariasis may also be
prevented by the use of mosquito netting, and this strategy, too, gets obscured when lymphatic
filariasis is termed a PCT disease [17].
Trachoma is another disease typically categorized as a PCT NTD [18]. The WHO “SAFE”
strategy for eliminating blinding trachoma has four parts: surgery for trichiasis (the S compo-
nent of the strategy), antibiotic mass distribution (A component), facial cleanliness (F compo-
nent), and environmental improvement (E component). When trachoma is labeled a PCT
NTD, the other critical parts of the strategy become easily forgotten and ignored. In places
where blinding trachoma has disappeared in concert with economic development, it is conceiv-
able that these non-MDA parts of the strategy have played a pivotal role.
Schistosomiasis and soil-transmitted helminthiasis are NTDs for which water, sanitation,
and hygiene (WASH) are extremely important components of the prevention and control
strategy [19,20]. Indeed, in the absence of WASH, there is rapid “reworming” after people have
been treated with deworming drugs [21]. Improved access to and use of sanitation is associated
with lower odds of infection with soil-transmitted helminths [20,22]. The role of WASH is par-
ticularly relevant when the goal is elimination of transmission [23].
Compared to the PCT NTDs, advocates for controlling IDM NTDs have had a harder time
attracting resources and developing and delivering implementation strategies. One might spec-
ulate that adherence to a PCT versus IDM distinction might have contributed to lack of aware-
ness of IDM diseases and the scarcity of resources for innovation, research, and development.
Moreover, with success in interrupting or significantly reducing transmission, MDA for PCT
NTDs such as lymphatic filariasis is being scaled back. The post-transmission era—for lym-
phatic filariasis and for other NTDs approaching elimination—will require enhanced surveil-
lance in order to rapidly detect pockets of recrudescent or ongoing transmission and initiate
targeted responses. Taken together, the initial focus of this PCT NTD is shifting to an IDM
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NTD, which again renders the distinction into the two categories problematic. What’s more,
now that MDA with ivermectin is being tried as a strategy for eliminating malaria, the question
arises whether malaria should be labeled a PCT disease [24]. Would that be helpful? What
might the impact of doing so be on the use of long-lasting insecticidal nets, indoor residual
spraying, and mosquito larval control? And into which category will we place those NTDs for
which vaccines will become available?
Finally, there is increasing recognition of the need to strengthen health systems and the
importance of intersectoral collaboration in tackling the NTDs [25,26]. The sectors that need
to play a role include urban development, water and sanitation, clinical health care and public
health, transportation, and agriculture, among others. It will be much harder to achieve real
collaboration among the different sectors if our language implies that the non-health sectors
are merely contributing ancillary, nonessential activities [27]. Moreover, people must have
access to curative drugs in health facilities (e.g., albendazole or mebendazole for soil-transmit-
ted helminthiasis and praziquantel for schistosomiasis) so that symptomatic patients can be
treated at any time and not just during MDA campaigns, perhaps once a year. Thus, PCT
NTDs become IDM NTDs that can be managed on a daily basis through strengthened health
systems where essential medicines are available.
We believe it is time to seriously rethink the practice of dividing NTDs into the allegedly
dichotomous categories of PCT versus IDM diseases because the unintended consequences—
the “collateral damage”—of using them is starting to outweigh the benefits. We are not saying
that the label of PCT NTD has no value. Instead, we are saying that these labels should be used
thoughtfully and carefully while we search for better ways to group and label these diseases.
We believe that this dichotomy represents the threat that Julio Frenk was talking about. We
can do better.
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